# Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis

> **NCT06341452** · NA · RECRUITING · sponsor: **Fresenius Medical Care Deutschland GmbH** · enrollment: 130 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control

## Key facts

- **NCT ID:** NCT06341452
- **Lead sponsor:** Fresenius Medical Care Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06341452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06341452, "Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06341452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*